Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: The importance of using updated and adequate social tariffs to calculate QALYs" / Spandonaro, F., Ayala, F., Berardesca, E., Chimenti, S., Girolomoni, G., Martini, P., Peserico, A., Polistena, B., Guerra, A.P., Vena, G.A., Altomare, G., Pinton, P.C.. - In: BIODRUGS. - ISSN 1173-8804. - 29:1(2015), pp. 71-72. [10.1007/s40259-015-0118-5]

Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: The importance of using updated and adequate social tariffs to calculate QALYs"

AYALA, FABIO;
2015

2015
Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: The importance of using updated and adequate social tariffs to calculate QALYs" / Spandonaro, F., Ayala, F., Berardesca, E., Chimenti, S., Girolomoni, G., Martini, P., Peserico, A., Polistena, B., Guerra, A.P., Vena, G.A., Altomare, G., Pinton, P.C.. - In: BIODRUGS. - ISSN 1173-8804. - 29:1(2015), pp. 71-72. [10.1007/s40259-015-0118-5]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/635125
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact